The active zone primes synaptic vesicles and clusters voltage-gated Ca2+ channels fast neurotransmitter release. Here the authors dissect the underlying molecular architecture and show that distinct protein machineries execute these functions.
Last month, researchers created an electronic link between the brains of two rats separated by thousands of miles. This was just another reminder that technology will one day make us telepaths. But how far will this transformation go? And how long will it take before humans evolve into a fully-fledged hive mind? We spoke to the experts to find out.
I spoke to three different experts, all of whom have given this subject considerable thought: Kevin Warwick, a British scientist and professor of cybernetics at the University of Reading; Ramez Naam, an American futurist and author of NEXUS (a scifi novel addressing this topic); and Anders Sandberg, a Swedish neuroscientist from the Future of Humanity Institute at the University of Oxford.
They all told me that the possibility of a telepathic noosphere is very real — and it’s closer to reality than we might think. And not surprisingly, this would change the very fabric of the human condition.
This is de Garis ESSAYS, i.e. 2–3 page opinion pieces on such themes as Species Dominance, Global State, Politics, Femtotech, Religion, Society, Education. Written, Read Aloud and Videoed by Prof. Dr. Hugo de Garis [email protected] https://profhugodegaris.wordpress.com
AI is shaking up industries — and software engineering is no exception.
In a leaked recording of a June fireside chat obtained by Business Insider, Amazon Web Services CEO Matt Garman reportedly told employees that AI is changing what being a software engineer means —and essentially changes the job description.
“If you go forward 24 months from now, or some amount of time — I can’t exactly predict where it is — it’s possible that most developers are not coding,” Garman said, adding later that the developer role would look different next year compared to 2020.
Research that began with a patient-driven discovery in the lab of YSM’s Carrie Lucas, PhD, could help in fighting autoimmune diseases.
Writing in Nature Immunology, Lucas and colleagues identify a signaling molecule found in immune cells that could be a target for future treatments.
A medical mystery served as the genesis for a Yale-led study that has promising implications for treating a range of autoimmune diseases.
A young girl entered the clinic suffering from blood cell abnormalities, difficulty breathing, and later, diarrhea. She also had been diagnosed with recurrent infections due to low levels of antibody production. Her doctors treated her with corticosteroids to reduce her lung and gut inflammation and immunoglobulin replacement therapy to restore her antibody levels.